REVEAL: Randomized EValuation of the Effects of Anacetrapib Through Lipid-modification
This study is currently recruiting participants.
Verified January 2013 by University of Oxford
Sponsor:
University of Oxford
Collaborator:
Merck
Information provided by (Responsible Party):
University of Oxford
ClinicalTrials.gov Identifier:
NCT01252953
First received: November 24, 2010
Last updated: January 30, 2013
Last verified: January 2013
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study is currently recruiting participants. |
|---|---|
| Estimated Study Completion Date: | January 2017 |
| Estimated Primary Completion Date: | January 2017 (Final data collection date for primary outcome measure) |
No publications provided by University of Oxford
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):